Nuo Therapeutics, Inc. (AURX)
CIK 1091596 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Nuo Therapeutics, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Aug 31, 2026 | 4/A | 0001437749-26-029257 |
| Aug 28, 2026 | 4 | 0001437749-26-029236 |
| Aug 17, 2026 | 8-K | 0001437749-26-028109 |
| Aug 14, 2026 | 10-Q | 0001437749-26-028053 |
| Jul 2, 2026 | 4 | 0001437749-26-022670 |
| Jul 2, 2026 | 4 | 0001437749-26-022661 |
| Jul 2, 2026 | 4 | 0001437749-26-022664 |
| Jul 2, 2026 | 4 | 0001437749-26-022662 |
| Jul 2, 2026 | 4 | 0001437749-26-022665 |
| Jun 5, 2026 | 4 | 0001437749-26-019768 |
| Jun 3, 2026 | SCHEDULE 13D/A | 0001674752-26-000002 |
| Jun 3, 2026 | 8-K | 0001437749-26-019199 |
| Jun 2, 2026 | 4/A | 0001437749-26-019244 |
| Jun 2, 2026 | 4 | 0001437749-26-019246 |
| May 14, 2026 | 8-K | 0001437749-26-017116 |
| May 14, 2026 | 10-Q | 0001437749-26-017104 |
| Mar 30, 2026 | 10-K | 0001437749-26-010360 |
| Feb 12, 2026 | SCHEDULE 13G/A | 0001437749-26-003953 |
| Jan 26, 2026 | 4 | 0001437749-26-002128 |
| Jan 26, 2026 | 8-K | 0001437749-26-002078 |
| Jan 26, 2026 | SCHEDULE 13D/A | 0001437749-26-002120 |
| Jan 5, 2026 | 4 | 0001437749-26-000431 |
| Dec 22, 2025 | 4 | 0001437749-25-038506 |
| Dec 17, 2025 | 8-K | 0001437749-25-038091 |
| Dec 11, 2025 | 4/A | 0001437749-25-037614 |